EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment Approaches for Refractory Mycoplasma genitalium Infection

Rachel Tenney, Ernesto R Portillo, Danilo Bacic Lima, Julian A Torres Isasiga iD

Open Forum Infectious Diseases · 30.03.2026 · 13 (Supplement_2) · S1381-S1389

DOI: 10.1093/ofid/ofag031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 30.03.2026. Verfasst von Rachel Tenney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Albert Einstein College of Medicine, Bronx, NewYork, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycoplasma genitalium is an increasingly recognized sexually transmitted infection (STI) associated with urethritis, cervicitis, and pelvic inflammatory disease. Its management, though, is complicated by rapid expansion of antimicrobial resistance. Because M. genitalium lacks a cell wall, treatment options are limited to macrolides, tetracyclines, and fluoroquinolones. Widespread macrolide resistance, along with rising fluoroquinolone and dual-class resistance, has made refractory infection a common and challenging clinical scenario. Current guidelines recommend staged, resistance guided-therapy using a doxycycline lead-in followed by azithromycin for macrolide-susceptible infection or moxifloxacin for macrolide-resistant infection. However, access to macrolide resistance testing remains inconsistent; fluoroquinolone resistance testing is largely unavailable in routine practice, and correlations between resistance markers and clinical failure are incomplete. This review summarizes contemporary standard-of-care treatment strategies and emerging approaches for resistant or refractory M. genitalium infection. It also highlights critical gaps in diagnostic capacity, clinical trial data, and the antimicrobial development pipeline for STIs.

Schlagwörter

Stichwörter der Autor:innen

Mycoplasma genitaliumSTIrefractory infectionsresistance

Autor:innen und Institutionen

  • Albert Einstein College of Medicine, Bronx, NewYork, USA.
  • Department of Internal Medicine, Division of Infectious Disease, Montefiore Medical Center, Bronx, NewYork, USA.

ORCID-Profile: Julian A Torres Isasiga

Zitieren

APA

Tenney, R., Portillo, E. R., Bacic Lima, D., & Torres Isasiga, J. A. (2026). Treatment Approaches for Refractory Mycoplasma genitalium Infection. Open Forum Infectious Diseases, 13(Supplement_2), S1381-S1389. https://doi.org/10.1093/ofid/ofag031

Vancouver

Tenney R, Portillo ER, Bacic Lima D, Torres Isasiga JA. Treatment Approaches for Refractory Mycoplasma genitalium Infection. Open Forum Infectious Diseases. 2026;13(Supplement_2):S1381-S1389. doi:10.1093/ofid/ofag031

BibTeX
@article{Tenney2026,
  author = {Tenney, Rachel and Portillo, Ernesto R and Bacic Lima, Danilo and Torres Isasiga, Julian A},
  title = {Treatment Approaches for Refractory Mycoplasma genitalium Infection},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {Supplement_2},
  pages = {S1381--S1389},
  doi = {10.1093/ofid/ofag031}
}
Kostenlos starten →